Selected Patents

1. THA analogs useful as cholinesterase inhibitors, U.S. Patent (5,886,007, Mar 23, 1999).
2. Bisfunctional acetylcholinesterase reactivators, U.S. Patent (5,929,093, Jul 27, 1999).
3. Dimeric 5-amino-5,6,7,8-tetrahydroquinolinones and their pharmaceutical use, U.S. Patent (6,472,408, Oct 29, 2002) and UK Patent (GB2360518, May 5, 2004).
4. Neo-Tryptophan, U.S. Patents (6,214,790, Apr 10, 2001; 6,765,099, Jul 20, 2004; 6,921,805, Jul 26, 2005; 7,098,307, Aug 29, 2006; 1,067,950, May 14, 2008; 7,642,231 B2, Jan 5, 2010).
5. Molecular Modeling for Metalloproteins, U.S. Patent (7,664,625 B2, Feb 16, 2010).
6. Efficient Loading and cleavage methods for solid-phase synthesis using chlorotrityl resins, U.S. Patent (7,427,260 B2, Sep 23, 2008).
7. Agents that inhibit flavivirus replication, U.S. Patent Application Pending.
8. Small-Molecule botulinum toxin inhibitors, U.S. Patent Applications Pending.
9. Antivrial compositions and methods, U.S. Patent Application Pending.
10. Small-molecule inhibitors of protein synthesis inactivating toxins, U.S. Patent Application Pending.